Search Results for "rapid"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for rapid. Results 321 to 330 of 541 total matches.
Formoterol (Foradil Aerolizer) For Asthma
The Medical Letter on Drugs and Therapeutics • May 14, 2001 (Issue 1104)
agonist with a more rapid onset of action than salmeterol, which is not an important advantage ...
Formoterol fumarate inhalation powder Foradil Aerolizer, a long-acting beta2-adrenergic receptor agonist, has been approved by the FDA for maintenance treatment of asthma and prevention of exercise-induced bronchospasm. The drug has been available in Europe for many years.
Dutasteride (Avodart) for Benign Prostatic Hyperplasia
The Medical Letter on Drugs and Therapeutics • Dec 23, 2002 (Issue 1146)
for treatment of BPH; they cause rapid relaxation of smooth muscle tone in the bladder neck, prostate
capsule ...
Dutasteride (Avodart - GlaxoSmithKline) is now available in the US for oral treatment of benign prostatic hyperplasia (BPH). It is similar to finasteride (Proscar - Merck), which has been marketed for this indication since 1992 and also, since 1998, for alopecia (Propecia - Medical Letter 1998; 40:25).
Methamphetamine Abuse
The Medical Letter on Drugs and Therapeutics • Aug 02, 2004 (Issue 1188)
are postponed, and sustained mental concentration becomes difficult and
may be replaced by a rapid flight ...
Methamphetamine, a highly addictive synthetic sympathomimetic, has again become important as a drug of abuse in the US. Its resurgence has been associated with unsafe sexual practices that have resulted in an increase in HIV transmission, particularly among men who have sex with men (SJ Semple et al, J Subst Abuse Treat 2002; 22:149; A Urbina and K Jones, Clin Infect Dis 2004; 38:890).
Acetylcysteine (Acetadote) for Acetaminophen Overdosage
The Medical Letter on Drugs and Therapeutics • Aug 15, 2005 (Issue 1215)
is rapidly depleted, and the excess NAPQI causes liver
damage. Acetylcysteine, which is also a sulfhydryl ...
Acetaminophen (paracetamol; Tylenol, and others) taken in overdosage can cause severe hepatic injury and death. Acetaminophen poisoning is treated with (N-)acetylcysteine. Available for many years in the US as a solution for inhalation therapy (Mucomyst, and others), it subsequently became available for oral use and was recently marketed in the US for intravenous (IV) use as Acetadote (Cumberland).
InstaRead Lithium System
The Medical Letter on Drugs and Therapeutics • Oct 10, 2005 (Issue 1219)
from Quest
Diagnostics costs $50.
CONCLUSION — The InstaRead Lithium System offers
a rapid, relatively ...
The InstaRead Lithium System (ReliaLAB), an office test that only requires a finger stick to measure lithium serum concentrations, has been cleared by the FDA and is now available. Standard methods for measuring lithium serum concentrations require venipuncture and transport of the specimen to commercial laboratories.
Nelarabine (Arranon) for T-Cell Acute Lymphoblastic Leukemia
The Medical Letter on Drugs and Therapeutics • Feb 13, 2006 (Issue 1228)
OF ACTION — Nelarabine is rapidly
demethylated to ara-G and subsequently converted to
active ...
Nelarabine (Arranon - GlaxoSmithKline), a prodrug of the deoxyguanosine analog 9-β-D-arabinofuranosylguanine (ara-G), has been approved by the FDA for treatment of patients with T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) that has not responded to, or has relapsed following, treatment with at least two chemotherapy regimens.
Drugs for MRSA with Reduced Susceptibility to Vancomycin
The Medical Letter on Drugs and Therapeutics • May 04, 2009 (Issue 1311)
(daptomycin is inactivated by
surfactant). Daptomycin is rapidly bactericidal, but
some S. aureus strains ...
The recent Medical Letter article on vancomycin dosing and monitoring briefly mentioned use of an alternative antibiotic for treatment of methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin. Some readers have asked for more information on this subject.
Click here to view the free full article.
Click here to view the free full article.
Ibalizumab-uiyk (Trogarzo) for Multidrug-Resistant HIV
The Medical Letter on Drugs and Therapeutics • Apr 23, 2018 (Issue 1545)
antiretroviral drug to a nonsup pressive
regimen because of the risk of rapid development
of resistance.4 ...
The FDA has approved ibalizumab-uiyk (Trogarzo –
Theratechnologies/TaiMed), a CD4-directed monoclonal
antibody, for IV treatment of multidrug-resistant
HIV-1 (MDR-HIV) infection in heavily
antiretroviral-experienced adults with treatment
failure on their current regimen. Ibalizumab-uiyk is
the first biologic drug to be approved by the FDA for
treatment of HIV-1 infection.
Drugs for Assisted Reproduction
Treatment Guidelines from The Medical Letter • Oct 01, 2003 (Issue 14)
), which
act on the ovary to stimulate oocyte growth. A rapid
increase in LH concentrations midcycle ...
Infertility occurs in about 15% of couples. About one third of infertility is due to problems with ovulation or an anatomic abnormality of the fallopian tube or peritoneum, such as scarring, adhesions or endometriosis. Another third is due to a male infertility factor, most commonly insufficient sperm production or abnormal motility or morphology. The remaining third is unexplained. In older women unexplained infertility is probably caused by diminished quality and quantity of oocytes, decreased implantation and spontaneous pregnancy wastage.
Drugs for COPD
The Medical Letter on Drugs and Therapeutics • Sep 02, 2024 (Issue 1710)
volume in one
second). Short-acting beta2-agonists have a more rapid
onset of action than ipratropium ...
The main goals of treatment of chronic obstructive
pulmonary disease (COPD) are to relieve symptoms,
reduce the frequency and severity of exacerbations,
prevent disease progression, and reduce mortality.
GOLD (Global Initiative for Chronic Obstructive Lung
Disease) guidelines for treatment of COPD were
updated recently. Treatment of acute exacerbations
is not discussed here. Drugs available for treatment
of COPD are listed in Tables 1 and 3.
Med Lett Drugs Ther. 2024 Sep 2;66(1710):137-44 doi:10.58347/tml.2024.1710a | Show Introduction Hide Introduction